Literature DB >> 6296999

Anti-inflammatory steroids without pituitary-adrenal suppression.

H J Lee, M R Soliman.   

Abstract

When two new steroids, methyl prednisolonate and methyl 20-dihydroprednisolonate, were applied locally their anti-inflammatory activities were nearly equivalent to those of the parent compound prednisolone in the cotton pellet granuloma bioassay. However, when these two derivatives were administered systemically, their anti-inflammatory activities were weaker than those of the parent compound. Furthermore, unlike the parent compound, these new anti-inflammatory steroids did not suppress pituitary-adrenal function or cause liver glycogen depletion in rats.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6296999     DOI: 10.1126/science.6296999

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  5 in total

Review 1.  Side effects of topical corticosteroids and their prevention.

Authors:  K Takeda; S Arase; S Takahashi
Journal:  Drugs       Date:  1988       Impact factor: 9.546

2.  Biological characterization of a novel class of toll-like receptor 7 agonists designed to have reduced systemic activity.

Authors:  M Biffen; H Matsui; S Edwards; A J Leishman; K Eiho; E Holness; G Satterthwaite; I Doyle; H Wada; N J Fraser; S L Hawkins; M Aoki; H Tomizawa; A D Benjamin; H Takaku; T McInally; C M Murray
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

3.  Inhibition by new glucocorticoid antedrugs [16α, 17α-d] isoxazoline and [16α, 17α-d]-3'-hydroxy-iminoformyl isoxazoline derivatives of chemotaxis and CCL26, CCL11, IL-8, and RANTES secretion.

Authors:  Younes J Errahali; Leeshawn D Thomas; Thomas C S Keller; Henry J Lee
Journal:  J Interferon Cytokine Res       Date:  2013-05-16       Impact factor: 2.607

Review 4.  Synthesis and pharmacology of anti-inflammatory steroidal antedrugs.

Authors:  M Omar F Khan; Henry J Lee
Journal:  Chem Rev       Date:  2008-12       Impact factor: 60.622

5.  A phase 3, multicenter, randomized, double-blind, vehicle-controlled, parallel-group study of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosis.

Authors:  Hiroo Yokozeki; Tomoko Fujimoto; Yoichiro Abe; Masaru Igarashi; Akiko Ishikoh; Tokuya Omi; Hiroki Kanda; Hiroto Kitahara; Miwako Kinoshita; Ichiro Nakasu; Naoko Hattori; Yuki Horiuchi; Ryuji Maruyama; Haruko Mizutani; Yoshiyuki Murakami; Chiharu Watanabe; Akihiro Kume; Takaaki Hanafusa; Masamitsu Hamaguchi; Akira Yoshioka; Yuriko Egami; Keizo Matsuo; Tomoko Matsuda; Motoki Akamatsu; Toshiyuki Yorozuya; Shinichi Takayama
Journal:  J Dermatol       Date:  2021-01-07       Impact factor: 4.005

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.